Similarly, no association was found between tOPN protein expression and sex, age, tumor size, extrathyroid extension, lymphovascular and/or capsular invasion, lymph node metastases, RET/PTC rearrangements, BRAFV600E, or RAS mutations. The gene discussed is RET; the disease is neoplasm.